Celebrating David Herman (1946 – 2020)
With deep sadness, we record the untimely death in London on June 3rd of our fellow Board Director, investor and friend, David Herman.
David served Hemanext as a member of the board for 10 years. He brought to this role a combination of intellectual rigor, vast and valuable experience gained over five decades of successful business leadership, a network of people who trusted his judgement and supported the growth of the company with their investments, unfailingly sound business judgement and advice, and a deep and humane commitment to Hemanext’s mission to improve the treatment of the millions of patients around the world who depend upon transfusion therapy to save and improve their lives.
A graduate of NYU and Harvard Law School, David became one of the most respected leaders in the international automotive industry. He steered some of the world’s most respected organizations as Chairman of Opel AG, President of SAAB, and as Overseas Vice President of General Motors Corporation. During his 30 years at GM, David oversaw a string of highly successful M&A transactions that led to the establishment of GM España, GM Poland, the takeover of SAAB, and the creation of a JV between GM, AvtoVAZ and the European Bank of Reconstruction and Development. After retiring from GM David also served as the Chairman of Sollers, a leading Russian vehicle and parts producer, and as the Chairman of the Audit and Compensation Committees of the Board of Golden Telecom.
We, his colleagues at Hemanext, will be forever grateful for the contributions he made to the development of our Company and for the unfailing kindness, humor and warmth he brought to the work of the Hemanext Board and team. To his wife Isabel, daughters Aniek and Nadine and family and friends around the world, we offer our deepest sympathies and condolences.
Click here for more information on David’s illustrious career.
Hemanext has made a donation in David’s memory to the Foundation of Circulatory Health and for anyone wishing to do so, the funds may be sent (via wire transfer) to:
St. Mary’s Coronary Flow Trust
The Bank of Scotland, Sort Code 1-01-03
A/c no 00690525
IBAN: GB87 BOFS 1201 0300 6905 25